Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres: I. In vitro characterization
- 3 October 2000
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 69 (1) , 53-67
- https://doi.org/10.1016/s0168-3659(00)00289-3
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59Vaccine, 1995
- Enhanced antibody production through sustained antigen release from biodegradable granulesJournal of Controlled Release, 1995
- Surface thermodynamic properties of synthetic hydrotalcite compoundsLangmuir, 1994
- Vaccine Delivery Systems: Potential Methods for Use in Antifertility VaccinesAmerican Journal of Reproductive Immunology, 1993
- Conformation and structure of mildly heat‐treated ovalbumin in dilute solutions and gel formation at higher protein concentrationsInternational Journal of Peptide and Protein Research, 1986
- In Vitro Drug Release from Egg Albumin MicrocapsulesJournal of Pharmaceutical Sciences, 1983
- The Complete Amino‐Acid Sequence of Hen OvalbuminEuropean Journal of Biochemistry, 1981
- Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouseInternational Journal of Immunopharmacology, 1979
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970